Connecticut Clinical Trials
Browse actively recruiting clinical trials with research sites in Connecticut. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Connecticut
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesNCT07088068PHASE3SanofiType 1 Diabetes MellitusNew Haven, CT
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsNCT06581432PHASE2Boehringer IngelheimSolid TumoursNew Haven, CT
- A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen SclerosusNCT07335588PHASE3LEO PharmaLichen SclerosusMiddlebury, CT
- A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityNCT06830863PHASE1, PHASE2Azitra Inc.EGFR Inhibitor-associated RashNew Haven, CT
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerNCT07525206PHASE3AbbVieColorectal CancerNew Haven, CT
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentNCT07708727PHASE2, PHASE3Gilead SciencesHIV-1-infectionNew Haven, CT
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerDanbury, CT
- A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)NCT06312176PHASE3Merck Sharp & Dohme LLCBreast NeoplasmsNew Haven, CT
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)NCT05564390PHASE2National Cancer Institute (NCI)Acute Myeloid LeukemiaNew Haven, CT
- Trientine Tetrahydrochloride Administered Once a Day for the First Line Treatment of Wilson's Disease Patients.NCT07465718PHASE3OrphalanWilson's DiseaseNew Haven, CT
- A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)NCT04302025PHASE2Genentech, Inc.Non-small Cell Lung CancerNew Haven, CT
- Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerNCT03606967PHASE2National Cancer Institute (NCI)Anatomic Stage IV Breast Cancer AJCC v8Hartford, CT
Clinical trials by Connecticut metro
Popular conditions in Connecticut
Frequently asked questions
- How do I find clinical trials in Connecticut?
- Corterve aggregates actively recruiting clinical trials with sites in Connecticut from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Connecticut free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Connecticut?
- Connecticut research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.